Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances •
BMS, Pharmasset in HCV Pact

January 10, 2011
Bristol-Myers Squibb and Pharmasset have entered into a clinical collaboration agreement to evaluate BMS-790052, a NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset’s nucleotide polymerase inhibitor for the treatment of ch  Read More »
Savient Provides Manufacturing Plans for Krystexxa

January 7, 2011
Savient Pharmaceuticals provided an update on its business activities related to the U.S. launch and commercialization of Krystexxa, a PEGylated uric acid specific enzyme for the treatment of chronic gout.  Read More »
Cambrex Zenara Supplies Product for India Nicorette Launch

January 7, 2011
Cambrex Zenara is supplying product for Johnson & Johnson Ltd.'s launch of smoking cessation drug Nicorette in India.  Read More »
AVI BioPharma

January 7, 2011
Effie Toshav, J.D., has been appointed senior vice president and general counsel at AVI BioPharma, effective January 10th.  Read More »
Emerald BioStructures Achieves Second UCB Milestone

January 7, 2011
Emerald BioStructures has successfully achieved the second milestone in its collaboration with UCB on the structure-based discovery of small molecule modulators of undisclosed targets.  Read More »
AMRI Consolidates Drug Discovery Platform

January 6, 2011
AMRI has merged its Discovery R&D and Discovery Chemistry departments to form a Global Drug Discovery organization.  Read More »
Seattle Genetics, Pfizer Enter ADC Pact

January 6, 2011
Seattle Genetics has entered into a collaboration agreement with Pfizer, under which Pfizer will pay $8 million upfront for rights to use Seattle Genetics’ antibody-drug conjugate (ADC) technology with antibodies to a single oncology target.  Read More »
Biogen Idec

January 6, 2011
Douglas E. Williams, Ph.D., has been named executive vice president of R&D at Biogen Idec and Steven H. Holtzman has been named executive vice president, corporate development.  Read More »
DSM Pharmaceutical Products

January 5, 2011
Wessels assumes responsibility for pharma unit  Read More »
Lonza Chooses IDBS EDM Solution

January 5, 2011
Bioprocess Execution System to help drive OpEx for Lonza clients  Read More »
PharmaNet Development Group

January 5, 2011
Derasp named VP Clinical Ops for Phase I  Read More »
MPI Research

January 5, 2011
Cooper named director of Clinical Medicine  Read More »
West Pharmaceutical Services

January 5, 2011
Hunt to succeed Ellers at $800 million unit  Read More »
Pfizer, Santaris Expand RNA Pact

January 4, 2011
Santaris Pharma and Pfizer have expanded their collaboration for the development and commercialization of RNA-targeted medicines using Santaris Pharma’s Locked Nucleic Acid (LNA) drug platform.  Read More »
AMRI, Genentech Enter Research Pact

January 4, 2011
AMRI has entered a research and licensing agreement with Roche subsidiary Genentech to develop antibacterial compounds from AMRI’s natural products sample collection.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: